Royalty Pharma hikes dividend by 4.8%
Royalty Pharma PLC (RPRX) has announced a 4.8% dividend hike to $0.22 quarterly per share for 2025. This marks the 5th consecutive year of increased dividends by RPRX.
Posts
Royalty Pharma hikes dividend by 11.8%
Royalty Pharma PLC (RPRX) has announced its second dividend hike since the pharmaceutical company became publicly listed in 2020 this year as one of the biggest initial public offerings in the United States. The company initiated a $0.15 per share quarterly dividend in 2020. Royalty Pharma will raise its dividend by 11.8 percent to $0.19 quarterly. This marks the second consecutive year with a double digit dividend hike by RPRX since the largest buyer of biopharmaceutical royalties initiated a 15 cent quarterly dividend in 2020. The dividend yield is 1.98%. Royalty Pharma will pay an estimated annual dividend of $461 million to its shareholders if we include this latest dividend hike. The next RPRX dividend will be paid on March 15, 2022, to shareholders of record at the close of business on February 18, 2022. Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating wi...
Royalty Pharma hikes dividend by 13.3%
Royalty Pharma PLC (RPRX) has announced its first dividend hike since the pharmaceutical company became publicly listed earlier this year as one of the biggest initial public offerings in the United States. The company initiated a $0.15 per share quarterly dividend in 2020 and will now hike its dividend by 13.3 percent to 17 cents per share quarterly. This increased dividend of $0.17 per share will be paid on March 15, 2021, to shareholders of record at the close of business on February 19, 2021. This results in a dividend yield of 1.3% based on a stock price of $51.27 and a new annual dividend rate of 68 cents per share. Royalty Pharma will pay an estimated annual dividend of $428 million to its shareholders if we include this latest dividend hike. Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and n...
Royalty Pharma initiates dividend
Royalty Pharma PLC (RPRX) has announced its first dividend since the pharmaceutical company became publicly listed earlier this year as one of the biggest initial public offerings in the United States. In the company's press release dated September 2, 2020 the company announces that the board of directors of Royalty Pharma plc has approved the payment of a dividend for the third quarter of 2020 of $0.15 per class A share. This first ever dividend of 15 cents per share will be paid on September 30, 2020, to shareholders of record at the close of business on September 15, 2020. This results in a dividend yield of 1.5% based on a stock price of $40.74 and an annual dividend rate of 60 cents per share. Royalty Pharma currently has a market cap of $34.9 billion. Shortly after the IPO the company's stock price touched an all time high of $56.50 on June 18, before dropping back to a low price of $39.90 on July 24. The stock price hasn't moved much since. Royalty Pharma will ...